Movement Disorders Flashcards

1
Q

Movement Disorders

A
  • result of dysfunction or damage to portions of the brain (basal ganglia)
  • to little movement (hypokinetic)
  • to much unwanted movement (hyperkinetic)
  • mixed movement disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Function of the Basal Ganglia

A

-Modulate Movement
Facilitate intended movements
Suppress unwanted movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hypokinetic Movement Disorders

A
  • Parkinson’s disease
  • Progressive supranuclear palsy
  • Multiple system atrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Parkinson’s Disease: Demographics

A

-common neurological disease
100 per 100,000 people (2000 in above age 60)
-unknown etiology, genetic factors important if onset before age 50, others important if later (env.)
-typical age of onset: 55-65
-life expectancy (with treatment) nears normal
-10% develop symptoms before 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Parkinson’s Disease: Neurologic Features

A
  • asymmetric onset - eventually bilateral
  • primary extrapyramidal features:
    1. rest tremor
    2. rigidity - inc. muscle tone in passive movement
    3. bradykinesia - hard to start/stop movement, slow to cary out, hard to repeat motion
    4. postural instability (late), balance impairment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Parkinson’s Disease: Motor Features

A
  • secondary extrapyramidal features
  • masked face - dec. facial expression
  • diminished blink frequency
  • stooped posture
  • small-stepped, shuffling gait
  • reduced armswing
  • hypokinetic dysarthria - softer, slurred speech
  • micrographia - smaller handwriting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Parkinson’s Disease: Non-Motor Features

A
  • depression 40-50%, may precede motor
  • anxiety 40%
  • cognitive impairment (frontal lobe (executive)) with progression: if early not it
    • executive: difficulty making decisions & carrying out plans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Parkinson’s Disease: Autonomic Dysfunction

A
  • Gastrointestinal: constipation
  • Urinary: over/under activing
  • Sexual: ED in men, dec. libido
  • Cardiovascular: orthostatic HTN
  • Thermoregulatory: sweating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Parkinson’s Disease: Others

A
  • olfactory dysfunction
  • visual dysfunction
  • sensory symptoms (pain)
  • Sleep disturbances (sleep fragmentation, REM sleep behavior disorder)
  • Fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Parkinson’s Disease: Pathologic Features

A
  • degeneration of pigmented neurons
    • substantia nigra pars compacta
    • locus ceruleus
    • dorsal vagal nucleus
  • Lewy body formation (cytoplasmic inclusion bodies) “fried egg” appearance
    • central/enteric nervous system
    • protein: alpha-synuclein (synucleinopathies)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Parkinson’s Disease: Neurochemical Features

A
  • Dopamine deficiency (nigrostriatal, mesolimbic, hypothalamic, retinal)
  • Norepinephrine
  • Serotonin
  • Glutamate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Progressive Supranuclear Palsy

A
  • characterized by features of Parkinsonism but some additional ones
  • Parkinsonism-plus syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Progressive Supranuclear Palsy: Demographics

A
  • sporadic
  • prevalence is 1-6.5 per 100,000
  • onset 50-60
  • life expectancy is ~10 yrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Progressive Supranuclear Palsy: Neurologic Features

A

Extrapyramidal Features

  • Rigidity: especially axial rigidity, may produce neck hyperextension, symmetric
  • Bradykinesia
  • “Astonished” facial expression
  • Dysarthria
  • gait disturbance (early)
  • postural instability (falling) (early)
  • tremor is unusual
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Progressive Supranuclear Palsy: Behavioral Features

A
  • emotional lability

- dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Progressive Supranuclear Palsy: Ophthalmologic Features

A
  • supranuclear gaze palsy
    • vertical (downwardgaze) first (messy eater, “dirty tie” sign, difficulty descending stairs
    • horizontal later
    • oculocephalic reflex intact
  • apraxia of eyelid opening (hard to open when asked, can do it spontaneously)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Progressive Supranuclear Palsy: Other Neurologic Features

A
  • pyramidal tract signs (Babinski sign)

- sleep disturbances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Progressive Supranuclear Palsy: Pathologic Features

A
  • Midbrain & cerebral cortical atrophy
  • Neuronal loss & gliosis (multiple areas)
  • Neurofibrillary tangles (globose type), composed of unpaired straight filaments, contain abnormally phosphorylated tau protein (tauopathy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Progressive Supranuclear Palsy: Neurochemical Features

A
  • striatal domamine deficiency

- dec. ACh, GABA, Norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Multiple System Atrophy

A

-Parkinsonism-plus syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Multiple System Atrophy: Demographics

A
  • Sporadic
  • Prevalence is 2.3-5.7 per 100,000
  • symptom onset typically age 50-55
  • life expectancy is ~5-10 yrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Multiple System Atrophy: Neurologic Featuers

A
  • present: parkinsonism, autonomic failure, or cerebellar syndrome
  • Extrapyramidal (89%)
  • Rigidity
  • Bradykinesia
  • Postural instability (early)
  • Tremor is unusual
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Multiple System Atrophy: Neurologic: Autonomic

A

78%

  • urinary dysfunction
  • orthostatic HTN
  • impotence (males)
  • gastrointestinal dysfunction
  • thermoregulatory dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Multiple System Atrophy Neurologic - Cerebellar

A

55%

  • ataxia
  • dysarthria
  • oculomotor abnormalities
  • exaggerated rebound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Multiple System Atrophy: Neurologic - Pyramidal

A

61%

  • hyperreflexia
  • Babinski responses
  • Spasticity
  • Psuedobulbar palsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Multiple System Atrophy: Neurologic - Behavioral

A

22%

  • personality changes
  • depression
  • cognitive dysfunction (frontal lobe executive dysfunction)
  • dementia typically does not develop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Multiple System Atrophy: Neurologic - Other

A
  • respiratory stridor, vocal cord abductor weakness, 33%, inc. sudden nocturnal death
  • involuntary sighing
  • Raynaud’s phenomenon
  • postural myoclonus of the hands
28
Q

Multiple System Atrophy: Pathologic Features

A
  • Cell loss & Gliosis: basal ganglia, brainstem, cerebellum, spinal cord
  • Glial cytoplasmic inclusion bodies
  • alpha-synuclein
29
Q

Multiple System Atrophy: Neurochemical Features

A

-not well characterized

30
Q

Hyperkinetic Movement Disorders

A
  • Huntington’s disease
  • Tourette’s Syndrome
  • Primary (idiopahtic) Dystonia
31
Q

Huntington’s Disease: Demographics

A
  • autosomal dominant inheritance (mutation on short arm of chromosome 4, expanded trinucleotide repeat, codes for “huntingtin” protein
  • onset 35-45
  • younger age of onset associated with more rapid course
  • after symptoms: life 15-20 yrs
32
Q

Huntington’s Disease: Neurologic - Extrapyramidal

A
  • chorea is common early
  • dystonia emerges as disease progresses
  • hyperkinetic dysarthria
  • Parkinsonism (juvenile form is onset)
  • Parkinsonism (advanced disease in adults)
33
Q

Chorea

A

-rapid, random jerky movements that seem to flow from one movement into another & impart a restless “wiggly” or dancing appearance to patient

34
Q

Dysarthria

A

-result of choreiform movements of the tongue & lips interfering with speech

35
Q

Huntington’s Disease: Neurologic - Behavioral

A
  • personality changes (impulsiveness, irritability, obsessive behavior, aggression)
  • depression
  • dementia (executive dysfunction, impairment of planning, organizing, reasoning, abstraction, judgement)
36
Q

Huntington’s Disease: Other Features

A
  • Oculomotor Disturbances (difficulty initiating saccades, slowed saccades, glazed impersistence)
  • Cachexia
37
Q

Huntington’s Disease: Pathologic Features

A
  • striatum (especially caudate), atrophy, neuronal loss, gliosis
  • cortex - atrophy, neuronal loss
38
Q

Tourette’s Syndrome: Demographics

A

100-1000 per 100,000

  • genetic mutation identified in a small fraction of patients; suspected in many more
  • 3:1 male predominance
  • symptom onset b/w age 2-15
  • symptoms often diminish in adulthood
  • normal life expactancy
39
Q

Tourette’s Syndrome: Clinical Features

A
  • Motor tics (stereotypic, sudden movements), may be simple or complex, preceded by a premoition or urge, may be temporarily suppressed
  • Vocal (phonic) tics - similar to motor tics but involve sound rather than movement
  • Sensory tics - may occur
  • Tics vary in location, frequency, character, & severity over time
40
Q

Tourette’s Syndrome: Formal Diagnostic Criteria

A
  • Multiple motor tics & at least one vocal tic must be present at some point during the course, though not necessarily concurrently
  • Tics must occur many times per day, almost every day or intermittently over the course of more than a year, wit no tic-free period of greater than 3 consecutive months
  • Onset must be before age 18
  • The disorder must not be explained by any other condition
41
Q

Motor Tics

A

Simple: muscle jerks, head shaking, shoulder shrugging, eye blinking, lip pouting
complex: jumping, throwing, clapping, touching, echopraxia (mimic others movement), copropraxia (obscene or forbidden gestures)

42
Q

Vocal Tics

A

Simple: sniffing, grunting, barking, hissing, clearing throat
Complex: words, phrases, sentences, echolalia (mimic vocal), palilalia (rapid repetition or echoing of one’s own words), coprolalia (swearing or obscene derogatory words)

43
Q

Tourette’s Syndrome: Behavioral Features

A
  • Attention deficit hyperactivity disorder: 35-90% of children with TS
  • Obsessive-Compulsive disorder: 30-50% of persons with TS
44
Q

Tourette’s Syndrome: Pathologic Features

A

-no abnormality has been identified y

45
Q

Tourette’s Syndrome: Neurochemical Features

A
  • no definitive abnormality
  • some dopaminergic disturbance suspected
  • others: monoaminergic (norepinephrine, serotonin,), opioid, adenosine
46
Q

Dystonia

A

-sustained muscle contraction that produces sustained, & sometimes repetitive, twisting movements that result in abnormal posture

47
Q

Dystonia can be Classified by?

A
  • Etiology: primary (unknown) & secondary (disease)

- Topographic distribution: generalized (muscles throughout the body) & focal (only one or a group)

48
Q

Dystonia: Demographics

A
  • estimated prevalence is 3 per 100,000
  • onset during childhood
  • Ashkenazi Jews
  • autosomal dominant inheritance (DYT1 gene mutation on chromosome 9, glutamate deletion in the protein, Torsin A, penetrance rate is 30-40%)
  • other mutations have also been identified
49
Q

Dystonia: Neurologic Features

A
  • focal onset
  • initially is action dystonia
  • lower extremity usually involved first (ankle inversion, plantar flexion of the toes)
  • axial muscles subsequently involved
  • gait & posture abnormalities develop “dromedary” appearance to gain, exaggerated hip abduction, knee hyperextension”
  • eventually these postures become fixed
  • dystonia remains sole feature (except for tremor in some)
50
Q

Dystonia: Pathologic Features

A

-no consistent abnormality

basal ganglia or cerebellum is origin

51
Q

Dystonia: Neurochemical Features

A
  • no consistent abnormality

- some studies show: dopamine, norepinephrine, GABA

52
Q

Primary Focal Dystonia: Demographics

A
  • adult onset
  • traditionally considered to be sporadic
  • genetic basis recently has been identified in some
  • 30 per 100,000
53
Q

Primary Focal Dystonia: Neurologic Features

A
  • various muscle groups affected
  • muscles are usually above the waist
  • typically progress over several years, then static
  • may be task-specific
  • may be relieved by sensory tricks
  • Cranial dystonia (Blepharospasm, Oromandibular, Laryngeal (spasmodic dysphonia))
  • Cervical Dystonia (spasmodic torticollis)
  • Limb Dystonia (Writer’s cramp, Musician’s dystonia)
54
Q

Primary Focal Dystonia: Pathologic Features

A

-no consistent abnormality

55
Q

Primary Focal Dystonia: Neurochemical Features

A

-no consistent abnormality

56
Q

Mixed Hypokinetic-Hyperkinetic Movement Disorders

A

-Wilson’s Disease

57
Q

Wilson’s Disease: Demographics

A
  • 3 per 100,000
  • 1 in 90 is a carrier
  • autosomal recessive inheritance (mutation long arm of chromosome 13, gene product is ATP7B, copper-transporting APTase, 380 mutations identified)
58
Q

Wilson’s Disease: Presentation

A

-onset 10-20, early as 3, late as 70s
-clinical presentation:
hepatic, neurologic, psychiatric

59
Q

Wilson’s Disease: Hepatic Features

A
  • acute transient hepatitis
  • acute fulminant hepatitis
  • chronic active hepatitis
  • progressive cirrhosis
60
Q

Wilson’s Disease: Neurologic Features

A
  • parkinsonism
  • chorea
  • dystonia
  • kinetic (intention) tremor
  • dysarthria
  • incoordination
61
Q

Wilson’s Disease: Psychiatric Features

A
  • personality change
  • depression
  • mania
  • psychosis
  • dementia
62
Q

Wilson’s Disease: Ophthalmologic Features

A
  • Kayser-Fleischer rings: brown pigment around the outer rim of the cornea (Cu deposits in Descemet’s membrane)
  • Sunflower Cataracts: only seen on slit-lamp exam, due to Cu deposits in the lens
63
Q

Wilson’s Disease: Pathologic Features

A
  • Cu deposition in various tissues
  • Hepatic fibrosis & cirrhosis
  • Neuronal loss & gliosis (putamen, thalamus, cerebral cortex)
  • Opalski cell formation (may originate from degenerating astrocytes)
64
Q

Opalski Cell

A

Seen in Wilson’s Disease

65
Q

Wilson’s Disease: Chemical Features

A
  • dec. serum ceruloplasmin
  • inc. serum free copper (dec. serum total copper, because of dec. ceruloplasmin)
  • inc. urinary copper
  • inc. hepatic Cu